Loading... Please wait...

Crinetics Pharmaceuticals, Inc. (CRNX) Financials

Currency in USD Disclaimer
$43.83 -$0.37 (-0.84%)
$43.78
$44.42
$15.76
$53.7
Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Operating Revenue $4.01 M $4.74 M $1.08 M $71,000.00 $1.19 M $2.43 M $2.05 M $589,000.00
Cost of Revenue $1.10 M $1.39 M $1.26 M $57.00 M $1.11 M $0.00 $0.00 $0.00
Gross Profit $2.92 M $3.35 M -$184,000.00 -$56.93 M $80,000.00 $2.43 M $2.05 M $589,000.00
Gross Profit Ratio 0.73 0.71 -0.17 -801.79 0.07 1 1 1
Research and Development Expenses $167.43 M $130.23 M $84.26 M $57.00 M $41.51 M $24.48 M $9.23 M $5.10 M
General & Administrative Expenses $58.09 M $42.39 M $24.53 M $18.03 M $13.52 M $6.66 M $1.94 M $1.53 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $58.09 M $42.39 M $24.53 M $18.03 M $13.52 M $6.66 M $1.94 M $1.53 M
Other Expenses -$159,000.00 $4.97 M $61,000.00 -$71,000.00 -$1.19 M $1.60 M -$48,000.00 -$1,000.00
Operating Expenses $225.52 M $172.62 M $108.78 M $74.95 M $53.83 M $28.71 M $9.13 M $6.04 M
Cost And Expenses $226.62 M $172.62 M $108.78 M $74.95 M $53.83 M $28.71 M $9.13 M $6.04 M
Interest Income $13.44 M $4.32 M $157,000.00 $991,000.00 $3.46 M $1.75 M $26,000.00 $37,000.00
Interest Expense $0.00 $4.32 M $0.00 $0.00 $0.00 $0.00 $8,000.00 $11,000.00
Depreciation & Amortization $1.10 M $983,000.00 $922,000.00 $948,000.00 $887,000.00 $471,000.00 $128,000.00 $92,000.00
EBITDA -$221.51 M -$167.88 M -$107.70 M -$74.95 M -$53.83 M -$28.71 M -$9.02 M -$5.92 M
EBITDA Ratio -55.2 -35.44 -99.91 -1055.68 -45.12 -11.82 -4.41 -10.04
Operating Income -$222.61 M -$167.88 M -$107.70 M -$74.95 M -$53.83 M -$28.71 M -$9.13 M -$6.04 M
Operating Income Ratio -55.47 -35.44 -99.91 -1055.68 -45.12 -11.82 -4.46 -10.26
Total Other Income/Expenses Net $8.08 M $3.96 M $61,000.00 $1.14 M $3.41 M $1.60 M -$48,000.00 -$1,000.00
Income Before Tax -$214.53 M -$163.92 M -$107.64 M -$73.81 M -$50.42 M -$27.12 M -$9.16 M -$6.02 M
Income Before Tax Ratio -53.46 -34.6 -99.85 -1039.61 -42.26 -11.17 -4.48 -10.22
Income Tax Expense $0.00 -$3.96 M -$922,000.00 -$948,000.00 -$887,000.00 $1.60 M -$40,000.00 $10,000.00
Net Income -$214.53 M -$159.95 M -$106.72 M -$72.86 M -$49.54 M -$27.12 M -$9.16 M -$6.02 M
Net Income Ratio -53.46 -33.77 -99 -1026.25 -41.52 -11.17 -4.48 -10.22
EPS -3.69 -3.08 -2.78 -2.39 -2.05 -2.23 -0.66 -0.43
EPS Diluted -3.69 -3.08 -2.78 -2.39 -2.05 -2.23 -0.66 -0.43
Weighted Average Shares Out $58.07 M $51.98 M $38.44 M $30.45 M $24.18 M $12.14 M $13.88 M $13.88 M
Weighted Average Shares Out Diluted $58.07 M $51.98 M $38.44 M $30.45 M $24.18 M $12.14 M $13.88 M $13.88 M
Link
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.